Segment Information (Details) $ in Thousands	3 Months Ended				6 Months Ended
	Jun. 30, 2025 USD ($)	Mar. 31, 2025 USD ($)	Jun. 30, 2024 USD ($)	Mar. 31, 2024 USD ($)	Jun. 30, 2025 USD ($) segment	Jun. 30, 2024 USD ($)
Segment Reporting [Abstract]
Number of reportable segments | segment					1
Segment Reporting Information [Line Items]
Interest income	$ 850		$ 1,793		$ 1,847	$ 3,766
Interest expense	(1,301)		(1,142)		(2,564)	(2,145)
Loss on extinguishment of debt	0		(553)		0	(553)
Other income, net	11		1,613		179	1,612
Net loss	(17,982)	$ (18,089)	(17,249)	$ (16,193)	(36,071)	(33,442)
Reportable Segment
Segment Reporting Information [Line Items]
Collaboration revenue	0		1,143		0	1,885
Clinical development	5,710		5,684		10,039	8,412
General and administrative support	3,486		3,621		7,309	7,360
Research and discovery	3,537		3,270		6,856	7,545
Manufacturing	2,610		4,472		6,698	8,865
Other segment expenses	2,199		3,056		4,631	5,825
Interest income	850		1,793		1,847	3,766
Interest expense	(1,301)		(1,142)		(2,564)	(2,145)
Loss on extinguishment of debt	0		(553)		0	(553)
Other income, net	11		1,613		179	1,612
Net loss	$ (17,982)		$ (17,249)		$ (36,071)	$ (33,442)